[1] 中国科学院.中国植物志[M].北京:科学出版社,2005,66:457-458.
[2] Zhu Y, Xie L, Chen G,et al. Effects of oridonin on prolifera-tion of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice[J]. Pharmazie, 2007,62(6):439-444.
[3] Guo Y, Shan Q, Gong Y P,et al. Anti-leukemia effect of oridonin on Ph+ acute lymphoblastic leukemia cell SUP-B15[J]. Zhonghua Xueyexue Zazhi,2012,33(6):439-443.
[4] Li X, Guo J M, Xu K, et al. Inhibitory mechanism of down-regulation expression of pp-GalNAc-T14 by oridonin on human renal carcinoma cells in vitro[J].Fudan Xuebao, Yixueban. 2012, 39(3):273-276, 292.
[5] Xu W,Sun J Z,et al. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma[J]. Acta Pharmacol Sin,2006,27(12):1642-1646.
[6] Nagao Y, Fujita E,Kohno T,et al. An efficient method for selective acetylation of alcoholic hydroxyl groups. Chem Pharm Bull[J]. 1981, 29:3202-3207.
[7] Xu J Y, Yang J Y, RanQ,et al. Synthesis and biological evaluation of novel 1-O-and 14-O-derivatives of oridonin as potential anticancer drug candidates[J]. Bioorg Med Chem Lett, 2008,18:4741-4744.
[8] Wang L, Ran Q, Li D H,et al. Synthesis and anti-tumor activity of 14-O-Derivatives of natural oridonin[J]. Chin J Nat Med,2011, 9(3):194-198.
[9] 徐星星,刘舒畅,王琴荣,等. 冬凌草甲素衍生物的合成及其抗白血病活性研究[J]. 中国药物化学杂志,2011, 21(1):1-6.
[10] 阎学斌,雷萌,张建业,等.冬凌草甲素葡萄糖苷的合成[J]. 有机化学, 2005, 25(2):222-224.
[11] 阎学斌,张建业,可钰, 等.冬凌草甲素芳胺类衍生物的合成及其抗肿瘤活性[J]. 郑州大学学报(医学版), 2007, 42(1):39-41.
[12] 南发俊,张仰明,刘桦南,等.一种对映-贝壳杉烷型二萜及其衍生物和制备方法:中国,102584760[P]. 2012-07-18.
[13] 徐进宜,王磊,张奕华,等. 具有抗肿瘤活性的ent-6,7-开环贝壳杉烯型冬凌草甲素衍生物、其制备方法及用途:中国,102002051B[P].2013-06-19.
[14] 徐进宜,李达翃,蔡浩,等. 具有抗肿瘤活性的冬凌草甲素及6,7-开环冬凌草甲素含氟衍生物、制备方法及用途:中国,102295649A[P].2011-12-28.